Lv3
310 积分 2022-12-13 加入
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
5个月前
已关闭
Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers
6个月前
已完结
Advances in small molecule maintenance therapies for high-grade serous ovarian cancer
7个月前
已完结
The Clinical Pathological Characteristics and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in Ovarian Cancer Patients: A Prospective Cohort Study
7个月前
已完结
A comprehensive literature review and meta‐analysis of the prevalence of pan‐cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies
7个月前
已完结
Decoding BRCA1 and BRCA2 mutations: implications of mutation type and domain location for PARP inhibitor response in ovarian cancer
7个月前
已关闭
Decoding BRCA1 and BRCA2 mutations: implications of mutation type and domain location for PARP inhibitor response in ovarian cancer
7个月前
已关闭
Decoding BRCA1 and BRCA2 mutations: implications of mutation type and domain location for PARP inhibitor response in ovarian cancer
8个月前
已关闭
[Association analysis on BRCA gene functional domain mutations and prognosis in patients with ovarian epithelial carcinoma and fallopian tube carcinoma]
8个月前
已完结
皖公网安备34019202002308
